SPY312.23+1.71 0.55%
DIA258.42+1.11 0.43%
IXIC10,207.63+53.00 0.52%

Cowen & Co. Initiates Coverage On Pliant Therapeutics with Outperform Rating

Cowen & Co. analyst Ritu Baral initiates coverage on Pliant Therapeutics (NASDAQ:PLRX) with a Outperform rating.

Benzinga · -
Cowen & Co. analyst Ritu Baral initiates coverage on Pliant Therapeutics (NASDAQ: PLRX) with a Outperform rating.